360° Coverage : Himachal High Court sets up panel on drug prices

Himachal High Court sets up panel on drug prices

Shimla, Dec 29 (IANS) Concerned over "inflated" prices of some life-saving drugs, the Himachal Pradesh High Court has constituted a committee of experts to guide the court on availability of cheap medicines.

Dec 29 2012, 6:33am CST | by

Himachal High Court sets up panel on drug prices
Photo Credit: STR, Getty Images

Shimla, Dec 29 — Concerned over "inflated" prices of some life-saving drugs, the Himachal Pradesh High Court has constituted a committee of experts to guide the court on availability of cheap medicines.

"No doubt the pharmaceutical companies are entitled to earn profits, but the profits must be reasonable profits," a division bench of Justice Deepak Gupta and Justice Sanjay Karol said in an order made available Saturday.

The court constituted a 13-members committee, comprising doctors of the Indira Gandhi Medical College and Hospital in Shimla and the Rajendra Prasad Medical College in Tanda in Kangra district, and asked it to guide it on lowest prices of medicines.

Hearing a public interest petition by Amardeep Chauhan alleging high prices of life-saving drugs, the judges observed: "Such an increase (in prices) shocks the judicial conscience of this court. The salt is the same. The drug is commonly manufactured. There is no patent with regard to the drug. It only shows that at the cost of poor patients, huge profits are being made."

The court directed pharma companies to file a reply stating what steps they were taking to ensure that drugs were available at the minimum costs.

Taking up the case of drug atorvastatin, used for heart ailments, the court said the drug manufactured by Hetero Labs Ltd and marketed by Gen X Pharma Ltd under the brand name of GenxVast cost Rs.12 for a pack of 10 tablets of 10 mg each.

The same manufacturer's drug marketed under brand name Lilo by Glaxo Smith Kline cost Rs.33.75 for a pack of 10 tablets of 10 mg each - almost three times more than GenxVast, the court said.

"The fact is that the same manufacturer is manufacturing an identical drug of identical potency under different brand names and pricing them differently. How can a poor patient, who comes from a rural background, confront a doctor or a chemist when he is sold an expensive medicine," asked the court.

The court would next hear the matter March 21.

IANS

Source: IANS

 
 
 

<a href="/latest_stories/all/all/8" rel="author">Luigi Lugmayr</a>
Luigi is the founding Chief Editor of I4U News and brings over 15 years experience in the technology field to the ever evolving and exciting world of gadgets. He started I4U News back in 2000 and evolved it into vibrant technology magazine.
Luigi can be contacted directly at ml@i4u.com. Luigi posts regularly on LuigiMe.com about his experience running I4U.

 

blog comments powered by Disqus

Latest stories

$75,000 Apple Watch revealed
$75,000 Apple Watch revealed
When Apple's designs are not exclusive enough then there are 3rd parties who add gold and diamonds to the iGadget to make them precious. Brikk announced the Lux Watch, a diamond studded version of the Apple Watch.
 
 
Sony will not Sell Off TV And Mobile Spinoffs
Sony will not Sell Off TV And Mobile Spinoffs
Sony President Kazuo Hirai clarified on Wednesday that the company will not immediately sell off the spun out TV and mobile phone business.
 
 
Apple Watch gets 12-page Vogue Magazine Ad
Apple Watch gets 12-page Vogue Magazine Ad
The March issue of Vogue Magazine packs 12 pages of Apple Watch ads.
 
 
Wearables that go beyond the Apple Watch
Wearables that go beyond the Apple Watch
Apple Watch is going to open a new chapter in wearables, but where is the future?